Results 151 to 160 of about 46,386 (217)

Differential regulation of monocyte oxidative burst by isoniazid in healthy and latent tuberculosis-infected subjects. [PDF]

Front Pharmacol
Gal J, Sönnerbrandt M, Braian C, Schön T, Blomgran R.   +4 more
europepmc   +1 more source

Discovery of novel InhA inhibitors through structural bioinformatics and machine learning-driven QSAR screening of natural products. [PDF]

Biol Methods Protoc
Anthony GI, Nwosu SN, Owolade AJ, Kehinde TO, Teye RG, Akor SE, Fabuyi FS, Nwafor IR, Oleh PK, Ilori TD, Bodun DS.   +10 more
europepmc   +1 more source

Acceptability and safety of one versus three months of rifapentine and isoniazid to prevent tuberculosis in people exposed in the household or workplace in Brazil: The Ultra-Curto randomized controlled trial. [PDF]

PLoS Med
Durovni B, Cordeiro-Santos M, Cavalcante SC, Spener-Gomes R, Garcia J, Cohn S, Saraceni V, Kohler B, Moulton LH, Brito da Souza A, Berihun A, Marzinke M, Chaisson RE, Ultra Curto Study Team.   +13 more
europepmc   +1 more source

First-line drug-resistant tuberculosis among children under 15 years in Ethiopia: insights from phenotypic and whole-genome sequencing approaches. [PDF]

BMC Infect Dis
Abebaw Y, Ayele A, Ghodousi A, Alemayehu DH, Gebremicael G, Diriba G, Seid G, Cabibbe AM, Abebe M, Sheth A, Argaw R, Abegaz WE.   +11 more
europepmc   +1 more source

Resistance to anti-TB drugs: evaluation of universal resistance surveillance implementation in Chile. [PDF]

IJTLD Open
Barra GN, Oyarte M, Ivani KK, Briceño ÁD, Espinoza IM, Calderón TL, Juica MM, Bordón AS, Oviedo JF, Muñoz FA.   +9 more
europepmc   +1 more source

Common Adverse Reactions and Management Strategies of First-Line Anti-Tuberculosis Drugs. [PDF]

Infect Drug Resist
He K, Zhang J, Du X, He X, Zeng Y, Liu M.   +5 more
europepmc   +1 more source

Pattern and prevalence of rifampicin and isoniazid-resistant tuberculosis using genotype MTBDR<i>plus</i> assay in Ethiopia. [PDF]

Microbiol Spectr
Getahun M, Ameni G, Mollalign H, Diriba G, Beyene D.   +4 more
europepmc   +1 more source

Naturally occurring dinactin targets cpsA protein and kills Mycobacterium tuberculosis by disrupting the proton motive force. [PDF]

Commun Biol
Wang G, Dong W, Bai Y, Li Y, Lu H, Lu W, Wang C, Tang J, Li P, Wang R, Wang X, Chen H, Tan C.   +12 more
europepmc   +1 more source

Evaluation of Xpert MTB/XDR and Deeplex Myc-TB for the Rapid Detection of Drug Resistance in <i>Mycobacterium tuberculosis</i>. [PDF]

Int J Microbiol
Park M, Solanki P, McHugh TD, Kon OM, Satta G.   +4 more
europepmc   +1 more source

A drug-resistant TB cluster in a refugee family with Mendelian susceptibility to mycobacterial disease (MSDM). [PDF]

IJTLD Open
Boktor HAZ, Monedero-Recuero I, Al Shatnawi A, Halaseh H, Nejm MA, Satyanarayana S, Wilson N, Dent R, Maaia I, Okkeh K.   +9 more
europepmc   +1 more source